Nanjing Medlander Medical Technology (688273)
- 36.03
- +1.08+3.09%
Nanjing Medlander Medical Technology (688273) News
Mailande (688273): Pursuing a Coordinated Development of Serious and Consumer Healthcare While Actively Expanding into the Brain-Computer Interface Business
Review of Mailande's (688273) 2025 Annual Report and 2026 First-Quarter Report: Steady Growth in Reproductive Rehabilitation Products; Groundbreaking Innovations in Brain-Computer Interface Technology
Mayland (688273) Investment Value Analysis Report: Focus on Women's Health and Beauty “Medical+Consumption” Two-wheel Drive
Mai Lande (688273) Comment: Global Strategy Cooperation Launches “Brain-computer Interface Interface+Intelligent Robotics” to Expand New Rehabilitation Applications
Mai Lander (688273): Reproductive rehabilitation grows rapidly and actively lays out potential Business
Mai Lander (688273): Reproductive rehabilitation performance is outstanding, and energy can be expected in many categories in the future
Mai Lander (688273): The pelvic floor business will grow steadily in 2024, and reproductive anti-aging will continue to grow at a high rate
Mayland (688273): The consumables business is growing rapidly and actively lays out a potential circuit
Mai Lander (688273): Stable income growth in 2024Q3, reproductive anti-aging, continued high growth
Mai Lander (688273): Performance is picking up significantly, and the reproductive anti-aging business is growing rapidly
Mai Lander (688273): The launch of the PI-ONE system is optimistic about high annual performance growth
Mai Lander (688273): Business stabilized and improved 24Q2 revenue increased by more than 30%
Mai Lander (688273): 2024Q2 improved significant reproductive resistance and became the second growth curve
Mai Lander (688273): Focus on pelvic floor health to create women's health and beauty
Mai Lander (688273): Female rehabilitation device leader's health and beauty strategy is beginning to emerge
Mai Lander (688273): Significant month-on-month improvement in 2024Q1 is expected to resume high growth throughout the year
Mai Lander (688273): Expanding Scenes and Expanding Domains
Mayland (688273): Rehabilitation leader for rapid pipeline iteration
Merrand (688273): 2023Q2 revenue fell slightly short of expectations, new products led to increased profitability
Research Report Nuggets 丨 Huaan Securities: New products are being promoted smoothly, medium- to long-term equity incentives point the direction for performance growth, and maintaining Mailand's “buy” rating